For pharmaceutical manufacturers, a deep understanding of technical specifications is fundamental when sourcing raw materials. Clindamycin Phosphate (CAS 24729-96-2) is a critical intermediate, and adherence to precise specifications ensures the safety and efficacy of the final drug product. This article highlights the key technical parameters that procurement specialists and R&D teams should consider when looking to buy Clindamycin Phosphate.

The purity of Clindamycin Phosphate is a paramount consideration. Reputable manufacturers typically guarantee a purity level of 99%. This high degree of purity is essential for minimizing impurities that could affect the drug's performance or lead to adverse patient reactions. When sourcing from a Chinese manufacturer, always request a detailed Certificate of Analysis (CoA) that explicitly states the purity percentage and the analytical methods used for its determination. This ensures that the product meets the stringent requirements for pharmaceutical intermediates.

Appearance is another important physical characteristic. Clindamycin Phosphate is generally described as a white powder. Deviations from this appearance could indicate contamination or degradation of the product. Therefore, visual inspection upon receipt, alongside CoA verification, is a vital quality control step for any pharmaceutical buyer. Ensuring you purchase from a trusted clindamycin phosphate supplier means receiving material that consistently meets this standard.

The molecular weight of Clindamycin Phosphate is approximately 504.96 g/mol. This figure is crucial for stoichiometric calculations in synthesis and formulation processes. Understanding the molecular weight helps in accurate dosing and in predicting the physical behavior of the compound during manufacturing. When comparing clindamycin phosphate price quotes from various suppliers, confirm that the molecular weight and formula (C18H34ClN2O8PS) are consistently stated and accurate.

Furthermore, understanding the intended application, such as for injectable formulations, provides context for these specifications. The enhanced solubility conferred by the phosphate group is a direct consequence of its chemical structure and molecular properties. By focusing on these technical details, pharmaceutical companies can confidently purchase Clindamycin Phosphate, ensuring the integrity of their drug development and manufacturing processes. For reliable sourcing of this intermediate, always engage with experienced clindamycin phosphate manufacturers.